Abstract
Toll-like receptors (TLR), a family of evolutionarily conserved pathogen recognition receptors, play pivotal role as primary sensors of invading pathogens. TLR identify molecular motifs of infectious agents (pathogen associated molecular patterns) and elicit an effective defensive response against them. Mammalian TLR derive their name from the Drosophila Toll protein, with which they share sequence similarity. So far, expression of 10 TLR is known in humans. The adaptor proteins, myeloid differentiation factor 88 and Toll IL-1 receptor (TIR) domain containing adaptor inducing IFN-β (TRIF) are the key players in the TLR signalling cascade leading to the activation of nuclear factor (NF)-κB and interferon regulatory factor-3, respectively. Targeted manipulation of the TLR signalling pathway has immense therapeutic potential and may eventually prove to be a boon in the development of innovative treatments for diverse disease conditions. There is accumulating evidence that TLR agonists have tremendous potential as novel therapeutic targets. In this review, we have discussed the immunobiology of TLR and emphasize significant advances made within the ever-expanding field of TLR that provide intriguing insights efficacious in unravelling the complexities associated with TLR.
| Original language | English |
|---|---|
| Pages (from-to) | 333-341 |
| Number of pages | 9 |
| Journal | Immunology and Cell Biology |
| Volume | 84 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2006 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Immunology
- Clinical Biochemistry
- Cell Biology
Cite this
Immunobiology of Toll-like receptors : Emerging trends. / Pandey, Saumya; Agrawal, Devendra K.
In: Immunology and Cell Biology, Vol. 84, No. 4, 08.2006, p. 333-341.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Immunobiology of Toll-like receptors
T2 - Emerging trends
AU - Pandey, Saumya
AU - Agrawal, Devendra K.
PY - 2006/8
Y1 - 2006/8
N2 - Toll-like receptors (TLR), a family of evolutionarily conserved pathogen recognition receptors, play pivotal role as primary sensors of invading pathogens. TLR identify molecular motifs of infectious agents (pathogen associated molecular patterns) and elicit an effective defensive response against them. Mammalian TLR derive their name from the Drosophila Toll protein, with which they share sequence similarity. So far, expression of 10 TLR is known in humans. The adaptor proteins, myeloid differentiation factor 88 and Toll IL-1 receptor (TIR) domain containing adaptor inducing IFN-β (TRIF) are the key players in the TLR signalling cascade leading to the activation of nuclear factor (NF)-κB and interferon regulatory factor-3, respectively. Targeted manipulation of the TLR signalling pathway has immense therapeutic potential and may eventually prove to be a boon in the development of innovative treatments for diverse disease conditions. There is accumulating evidence that TLR agonists have tremendous potential as novel therapeutic targets. In this review, we have discussed the immunobiology of TLR and emphasize significant advances made within the ever-expanding field of TLR that provide intriguing insights efficacious in unravelling the complexities associated with TLR.
AB - Toll-like receptors (TLR), a family of evolutionarily conserved pathogen recognition receptors, play pivotal role as primary sensors of invading pathogens. TLR identify molecular motifs of infectious agents (pathogen associated molecular patterns) and elicit an effective defensive response against them. Mammalian TLR derive their name from the Drosophila Toll protein, with which they share sequence similarity. So far, expression of 10 TLR is known in humans. The adaptor proteins, myeloid differentiation factor 88 and Toll IL-1 receptor (TIR) domain containing adaptor inducing IFN-β (TRIF) are the key players in the TLR signalling cascade leading to the activation of nuclear factor (NF)-κB and interferon regulatory factor-3, respectively. Targeted manipulation of the TLR signalling pathway has immense therapeutic potential and may eventually prove to be a boon in the development of innovative treatments for diverse disease conditions. There is accumulating evidence that TLR agonists have tremendous potential as novel therapeutic targets. In this review, we have discussed the immunobiology of TLR and emphasize significant advances made within the ever-expanding field of TLR that provide intriguing insights efficacious in unravelling the complexities associated with TLR.
UR - http://www.scopus.com/inward/record.url?scp=33745077384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745077384&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1711.2006.01444.x
DO - 10.1111/j.1440-1711.2006.01444.x
M3 - Review article
C2 - 16834572
AN - SCOPUS:33745077384
VL - 84
SP - 333
EP - 341
JO - Immunology and Cell Biology
JF - Immunology and Cell Biology
SN - 0818-9641
IS - 4
ER -